Quantification of co-trimoxazole in serum and plasma using MS/MS.

about

UPLC-MS/MS method for therapeutic drug monitoring of 10 antibiotics used in intensive care units.

P2860

Q48016535-2889F710-C66A-4DBF-BC93-CA90EE1E29FE

P2860

Quantification of co-trimoxazole in serum and plasma using MS/MS.

Item

http://www.wikidata.org/entity/Q38942938

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Quantification of co-trimoxazole in serum and plasma using MS/MS.

@en

type

Item

label

Quantification of co-trimoxazole in serum and plasma using MS/MS.

@en

prefLabel

Quantification of co-trimoxazole in serum and plasma using MS/MS.

@en

P1476

Quantification of co-trimoxazole in serum and plasma using MS/MS.

@en

P2093

Ben Greijdanus

http://www.w3.org/2001/XMLSchema#string

Daan J Touw

http://www.w3.org/2001/XMLSchema#string

Jacob A Dijkstra

http://www.w3.org/2001/XMLSchema#string

Jan-Willem C Alffenaar

http://www.w3.org/2001/XMLSchema#string

Kai van Hateren

http://www.w3.org/2001/XMLSchema#string

Noor Si Alsaad

http://www.w3.org/2001/XMLSchema#string

P2860

Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis

Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis

Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.

Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.

Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systematic review and meta-regression.

Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.

Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials.

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)

Matrix effect elimination during LC-MS/MS bioanalytical method development.

Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia.

P304

2741-2749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/BIO.15.188

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26566213

http://www.w3.org/2001/XMLSchema#string

Quantification of co-trimoxazole in serum and plasma using MS/MS.

about

P2860

P2860

Quantification of co-trimoxazole in serum and plasma using MS/MS.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698